Alícia da Costa Pereira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alícia da Costa Pereira has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Luis Konrath
Postgraduate Program in Pharmaceutical Science, Faculty of Pharmacy, Universidade Federal do Rio Grande do Sul (UFRGS), Brazil
2 shared publications - Alexandre M. Fuentefria
Postgraduate Program in Pharmaceutical Science, Faculty of Pharmacy, Universidade Federal do Rio Grande do Sul (UFRGS), Brazil; Postgraduate Program in Pharmacology and Therapeutics, Institute of Basic Health Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
1 shared publication - Daiana Daniele Boeff
Laboratory of Pharmacognosy, Faculty of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil
1 shared publication - Elisa Schmitt Rusch
Laboratory of Pharmacognosy, Faculty of Pharmacy, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90010-150, Brazil
1 shared publication - Jade André de Souza
Postgraduate Program in Pharmaceutical Science, Faculty of Pharmacy, Universidade Federal do Rio Grande do Sul (UFRGS), Brazil
1 shared publication - Letícia F. G. Kinape
Postgraduate Program in Pharmacology and Therapeutics, Institute of Basic Health Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
1 shared publication
Latest Publications
- Open Access
- 5 July 2026
- Published by Elsevier in Journal of Medical Mycology
- Vol. 36 (3) , 101637
Alkaloid hyemaline exhibits novel in vitro and in vivo antidermatophytic activity
- 5 July 2026
- Published by Elsevier in Journal of Medical Mycology
- Vol. 36 (3) , 101637
Open AccessAlkaloid hyemaline exhibits novel in vitro and in vivo antidermatophytic activity
- Open Access
Nephroprotective Plant Species Used in Brazilian Traditional Medicine for Renal Diseases: Ethnomedical, Pharmacological, and Chemical Insights
The prevalence of kidney-related diseases has been increasing and has emerged globally as a leading cause of mortality, especially in developing countries where they are considered a neglected public health problem. Renal diseases are commonly progressive and may cause irreversible loss of organ function, eventually necessitating renal replacement therapy. Although different pharmaceuticals are considered for the treatment of these pathologies, the uncertain effectiveness and presence of adverse effects have generated a growing need for the development of novel nephroprotective compounds. Because many medicinal herbs are typically used in Brazilian folk medicine to prevent and cure kidney ailments, ethnomedicine may play a promising and strategic role in identifying and adding new potential molecules to the pharmacological arsenal. This review focuses on the use of plants and secondary metabolites belonging to different classes to treat renal diseases, associating the screened plant extracts with the bioactive components present in each species. Flavonoids and triterpenes are notable metabolites that have therapeutic potential. The putative pharmacological mechanisms related to nephroprotective properties are also discussed in in vitro and in vivo models, when available.
Open AccessNephroprotective Plant Species Used in Brazilian Traditional Medicine for Renal Diseases: Ethnomedical, Pharmacological, and Chemical Insights
The prevalence of kidney-related diseases has been increasing and has emerged globally as a leading cause of mortality, especially in developing countries where they are considered a neglected public health problem. Renal diseases are commonly progressive and may cause irreversible loss of organ function, eventually necessitating renal replacement therapy. Although different pharmaceuticals are considered for the treatment of these pathologies, the uncertain effectiveness and presence of adverse effects have generated a growing need for the development of novel nephroprotective compounds. Because many medicinal herbs are typically used in Brazilian folk medicine to prevent and cure kidney ailments, ethnomedicine may play a promising and strategic role in identifying and adding new potential molecules to the pharmacological arsenal. This review focuses on the use of plants and secondary metabolites belonging to different classes to treat renal diseases, associating the screened plant extracts with the bioactive components present in each species. Flavonoids and triterpenes are notable metabolites that have therapeutic potential. The putative pharmacological mechanisms related to nephroprotective properties are also discussed in in vitro and in vivo models, when available.